StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > where is the news

<< Previous

Bullboard Posts

Next >>

Comment by Jonnyboy85on Feb 22, 2021 9:40pm

98 Views

Post# 32633611

RE:RE:RE:RE:where is the news

Sounds like buying talk to me. Sad to see all these accounts turn on everyone and start selfishly trying to manipulate people here to bolster their position before Aristotle and Q4/Q1 rev reporting. Look at the charts, the markets already decided what direction this stock was going months ago. quit giving in to your ugliest sides and buy back, join the party

RelevantStock wrote:
LithLover wrote: Over promise under deliver

Not sure I understand, what's wrong?.. The lab is printing money rn and they announced Aristotle for Q1 on multiple platforms.

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading